XML 61 R12.htm IDEA: XBRL DOCUMENT v2.4.0.6
Share-Based Compensation
6 Months Ended
Jun. 30, 2012
Share-Based Compensation

NOTE F – SHARE-BASED COMPENSATION

Share-based compensation cost is measured at the grant date based on the fair value of the award and is recognized over the service period, which is typically the same as the vesting period. The vesting period for the share-based compensation awarded by the Company is generally three years. The Company uses the Black-Scholes option pricing model to determine the fair value of stock option grants. The Company uses the closing market price of its common stock on the date of grant to determine the fair value of restricted stock and restricted stock units.

The Company used the following assumptions for the Black-Scholes option-pricing model to determine the fair value of options granted during the six months ended June 30, 2012 and July 2, 2011:

 

     For the Six Months Ended
     June 30, 2012   July 2, 2011

Risk-free interest rate

   0.61% - 0.66%   1.12% - 1.83%

Expected dividend yield

   0%   0%

Expected option life

   4 years   4 years

Expected volatility

   50.4% - 50.7%   47.9% - 48.7%

Weighted-average expected volatility

   50.7%   48.7%

Historical information was the primary basis for the selection of the expected dividend yield, expected volatility and the expected lives of the options. The risk-free interest rate was based on yields of U.S. zero coupon issues and U.S. Treasury issues, with a term equal to the expected life of the option being valued.

 

The Company recorded total share-based compensation expense of $1,093 and $723 for the three months ended June 30, 2012 and July 2, 2011, respectively, and $1,929 and $1,394 for the six months ended June 30, 2012 and July 2, 2011, respectively.

A summary of stock option activity and weighted average exercise prices for the six months ended June 30, 2012 follows:

 

     Options     Weighted-
Average
Exercise Price
     Weighted-
Average
Remaining
Contractual Term
     Aggregate Intrinsic
Value as of
June 30, 2012
 

Outstanding at January 1, 2012

     865,445      $ 26.72         

Granted

     240,866        57.00         

Forfeited

     (17,557     30.01         

Exercised

     (231,109     24.23         
  

 

 

   

 

 

    

 

 

    

 

 

 

Outstanding at June 30, 2012

     857,645      $ 35.84         5.0       $ 8,944   
  

 

 

   

 

 

    

 

 

    

 

 

 

Options exercisable at June 30, 2012

     389,619      $ 24.54         3.7       $ 6,834   
  

 

 

   

 

 

    

 

 

    

 

 

 

The weighted-average grant-date fair value of the stock options granted during the six months ended June 30, 2012 and July 2, 2011 was $22.57 and $14.17 per option, respectively. The total intrinsic value of stock options exercised during the three months ended June 30, 2012 and July 2, 2011 was $0.4 million and $5.2 million, respectively. The total intrinsic value of stock options exercised during the six months ended June 30, 2012 and July 2, 2011 was $6.5 million and $7.0 million, respectively. The fair value of stock options vested during the three months ended June 30, 2012 and July 2, 2011 was $0.0 million and $0.0 million, respectively. The total fair value of stock options vested during the six months ended June 30, 2012 and July 2, 2011 was $1.7 million and $1.6 million, respectively.

The following table summarizes the restricted stock and restricted stock unit activity and weighted average grant-date fair values for the six months ended June 30, 2012:

 

     Shares     Weighted-
Average
Grant  Date

Fair Value
 

Non-vested at January 1, 2012

     43,527      $ 32.31   

Granted

     12,719        49.98   

Forfeited

     (1,619     27.39   

Vested

     (17,160     35.45   
  

 

 

   

 

 

 

Non-vested at June 30, 2012

     37,467      $ 40.85   
  

 

 

   

 

 

 

As of June 30, 2012, there was $8.5 million of total unrecognized stock-based compensation expense related to non-vested stock-based compensation arrangements. The expense is expected to be recognized over a weighted average period of 2.2 years.